Vanguard Capital Management
NDRA icon

Vanguard Capital Management’s ENDRA Life Sciences NDRA Stock Holding History

Vanguard Capital Management’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1K Buy
7,339
+4,523
+161% +$23K ﹤0.01% 3956
2026
Q1 		$13.1K Buy
+2,816
New +$11.2K ﹤0.01% 4003

Other funds holding NDRA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Vanguard Capital Management's NDRA Position: Q2 2026 in Review

Vanguard Capital Management increased its ENDRA Life Sciences (NDRA) stake by 161% in Q2 2026, buying an estimated $23K and bringing the position to 7,339 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3956.

Vanguard Capital Management first reported a position in NDRA in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold NDRA as of Q2 2026.

  • Vanguard Capital Management held 7,339 shares of ENDRA Life Sciences worth $39.1K as of Q2 2026.
  • Vanguard Capital Management bought 4,523 ENDRA Life Sciences shares in Q2 2026, an estimated $23K.
  • ENDRA Life Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3956 holding.
  • Vanguard Capital Management first reported a position in ENDRA Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.